Enhanced generation and resolution of fibrin in women above the age of 30 years using oral contraceptives low in estrogen
- 1 July 1990
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 163 (1), 438-442
- https://doi.org/10.1016/0002-9378(90)90597-z
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study.BMJ, 1989
- The risk of thrombosis in hereditary protein S deficiency in a Scandinavian familyFibrinolysis, 1989
- A simplified estimation of tissue plasminogen activator (t-PA) inhibition in human plasmaFibrinolysis, 1987
- A Collaborative Study of a Proposed International Standard for Tissue Plasminogen Activator (t-PA)Thrombosis and Haemostasis, 1985
- Oral contraceptives and cardiovascular disease: some questions and answers.BMJ, 1982
- The use of evacuated glass tubes for collection of blood samples for fibrinolytic assaysThrombosis Research, 1982
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981
- SUBCUTANEOUS HEPARIN FOR THROMBOSIS IN PREGNANT WOMEN WITH HEREDITARY ANTITHROMBIN DEFICIENCYThe Lancet, 1979
- HÆMOSTATIC, LIPID, AND BLOOD-PRESSURE PROFILES OF WOMEN ON ORAL CONTRACEPTIVES CONTAINING 50 µg OR 30 µg ŒSTROGENThe Lancet, 1977